Kits Eyecare Ltd. (KTYCF,KITS.TO), a digital eyecare platform, provided preliminary results for its first quarter ended March 31, 2026, reflecting 23% year-over-year revenue growth but missing guidance.
For the first quarter, the firm reported preliminary revenue of $57.4 million, 23% higher than $46.6 million in the prior year. Meanwhile, this is below the earlier projected first-quarter revenue guidance of $58 million to $60 million.
Preliminary glasses revenue jumped approximately 61% to $10.8 million from $6.7 million in the year-ago period, exceeding the February 2026 guidance of $10 million.
As of now, the firm reported a cash position of $18.9 million. The company looks forward to reporting its full first quarter 2026 results in early May 2026.
KTYCF has traded between $6.93 and $16.38 in the last year. The stock closed Tuesday's trade at $11.25, up 0.46%.
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.